Xiaole Shirley Liu

Citée par

	Toutes	Depuis 2020
Citations	99525	55607
indice h	128	95
indice i10	249	213

13000

6500

3250

9750

200520062007200820092010201120122013201420152016201720182019202020212022202320242025366 512 738 993 1287 1683 2452 2976 3346 3913 4109 4433 4784 5238 6118 7400 10021 12108 11307 11859 2886

Accès public

Tout afficher

203 articles

0 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Myles BrownEmil Frei III Professor of Medicine, Dana-Farber Cancer Institute and Harvard Medical SchoolAdresse e-mail validée de dfci.harvard.edu
Cliff MeyerDana-Farber Cancer Institute and Harvard T.H. Chan School of Public HealthAdresse e-mail validée de jimmy.harvard.edu
Yong Zhang 张勇Professor of Bioinformatics, Tongji UniversityAdresse e-mail validée de tongji.edu.cn
Jun S LiuProfessor of statistics, Harvard UniversityAdresse e-mail validée de stat.harvard.edu
Tao LiuAssociate Professor, Roswell Park Comprehensive Cancer CenterAdresse e-mail validée de roswellpark.org
Wei LiGrace B. Bell Endowed Chair and Professor of Bioinformatics, University of California IrvineAdresse e-mail validée de uci.edu
Bo LiAssociate Professor, University of PennsylvaniaAdresse e-mail validée de chop.edu
Peng JiangSenior Investigator, National Cancer Institute, NIHAdresse e-mail validée de nih.gov
Wei LiAssociate Professor, Children's National Hospital, George Washington UniversityAdresse e-mail validée de childrensnational.org
Housheng Hansen HePrincess Margaret Cancer Centre, University Health Network; Department of Medical BiophysicsAdresse e-mail validée de uhnresearch.ca
Tengfei XiaoCTO, GV20 OncotherapyAdresse e-mail validée de bioxbh.com
Chongzhi ZangAssociate Professor, University of VirginiaAdresse e-mail validée de virginia.edu
Yiwen ChenAssociate Professor at University of Texas MD Anderson Cancer CenterAdresse e-mail validée de mdanderson.org
Shengqing (Stan) GuThe University of Texas MD Anderson Cancer CenterAdresse e-mail validée de mdanderson.org
Jingxin FuResearch Scientist, Medical Oncology Department, Dana-Farber Cancer InstituteAdresse e-mail validée de ds.dfci.harvard.edu
Taiwen LiAssociate Professor, West China Hospital of Stomatology, Sichuan UniversityAdresse e-mail validée de scu.edu.cn
Jingyu FanDepartment of Immunology, University of PittsburghAdresse e-mail validée de pitt.edu
Xihao HuGV20 TherapeuticsAdresse e-mail validée de gv20therapeutics.com
Jason CarrollUniversity of CambridgeAdresse e-mail validée de cruk.cam.ac.uk
Bradley BernsteinProfessor of Pathology, Harvard UniversityAdresse e-mail validée de broadinstitute.org

Suivre

Xiaole Shirley Liu

CEO, GV20 Therapeutics

Adresse e-mail validée de ds.dfci.harvard.edu - Page d'accueil

Computational Biology Immuno-Oncology AI Drug Discovery


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Model-based analysis of ChIP-Seq (MACS) Y Zhang, T Liu, CA Meyer, J Eeckhoute, DS Johnson, BE Bernstein, ... Genome biology 9 (9), 1, 2008	17255	2008
TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells T Li, J Fan, B Wang, N Traugh, Q Chen, S Liu, B Li, XS Liu Cancer Res 77 (1), e108-110, 2017	5066	2017
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response P Jiang, S Gu, D Pan, J Fu, A Sahu, X Hu, Z Li, N Traugh, X Bu, B Li, J Liu, ... Nature medicine 24 (10), 1550-1558, 2018	3905	2018
TIMER2. 0 for analysis of tumor-infiltrating immune cells T Li, J Fu, Z Zeng, D Cohen, J Li, Q Chen, B Li, XS Liu Nucleic acids research 48 (W1), W509-W514, 2020	3872	2020
ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia SG Landt, GK Marinov, A Kundaje, P Kheradpour, F Pauli, S Batzoglou, ... Genome research 22 (9), 1813-1831, 2012	2359	2012
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens LXS Li W, Xu H, Xiao T, Cong L, Love MI, Zhang F, Irizarry RA, Liu JS, Brown M Genome Biol 15 (12), 554, 2014	2297*	2014
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy B Li, E Severson, JC Pignon, H Zhao, T Li, J Novak, P Jiang, H Shen, ... Genome biology 17 (1), 1-16, 2016	2155	2016
Identifying ChIP-seq enrichment using MACS J Feng, T Liu, B Qin, Y Zhang, XS Liu Nature protocols 7 (9), 1728-1740, 2012	1794	2012
Genome-wide analysis of estrogen receptor binding sites JS Carroll, CA Meyer, J Song, W Li, TR Geistlinger, J Eeckhoute, ... Nature genetics 38 (11), 1289-1297, 2006	1645	2006
Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1 JS Carroll, XS Liu, AS Brodsky, W Li, CA Meyer, AJ Szary, J Eeckhoute, ... Cell 122 (1), 33-43, 2005	1601	2005
Expanded encyclopaedias of DNA elements in the human and mouse genomes JE Moore, MJ Purcaro, HE Pratt, CB Epstein, N Shoresh, J Adrian, T Kawli, ... Nature 583 (7818), 699-710, 2020	1598	2020
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2 M Ko, Y Huang, AM Jankowska, UJ Pape, M Tahiliani, HS Bandukwala, ... Nature 468 (7325), 839-843, 2010	1543	2010
Integrative analysis of the Caenorhabditis elegans genome by the modENCODE project MB Gerstein, ZJ Lu, EL Van Nostrand, C Cheng, BI Arshinoff, T Liu, ... Science 330 (6012), 1775-1787, 2010	1159	2010
FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription M Lupien, J Eeckhoute, CA Meyer, Q Wang, Y Zhang, W Li, JS Carroll, ... Cell 132 (6), 958-970, 2008	1143	2008
BioProspector: discovering conserved DNA motifs in upstream regulatory regions of co-expressed genes. X Liu, DL Brutlag, JS Liu Pacific symposium on biocomputing 6, 127-138, 2001	1118	2001
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ... Cell 138 (2), 245-256, 2009	1092	2009
A single-cell and spatially resolved atlas of human breast cancers SZ Wu, G Al-Eryani, DL Roden, S Junankar, K Harvey, A Andersson, ... Nature genetics 53 (9), 1334-1347, 2021	1014	2021
The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24^– stem cell–like breast cancer cells in human tumors LLC Marotta, V Almendro, A Marusyk, M Shipitsin, J Schemme, SR Walker, ... The Journal of clinical investigation 121 (7), 2723-2735, 2011	1013	2011
Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells WA Pastor, UJ Pape, Y Huang, HR Henderson, R Lister, M Ko, ... Nature 473 (7347), 394-397, 2011	994	2011
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ... Science 338 (6113), 1465-1469, 2012	992	2012

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs